AI-driven drug discovery and synthesis

During neurotransmitter release events in synaptic plasticity regulation

neurotransmitter release synaptic plasticity neuroscience molecular mechanisms brain function

CRISPR-Cas12a gene editing for immediate pandemic response in zoonotic viruses

viral diagnostics one-health approach portable biosensors outbreak containment

Integrating neutrino physics with medical imaging for deep-tissue cancer detection

particle oncology subatomic imaging tumor margin mapping hadron therapy

During circadian rhythm minima to optimize timed drug delivery in chronotherapy

circadian rhythms chronotherapy drug delivery precision medicine pharmacokinetics

Quantum annealing methods for protein folding prediction in computational biology

quantum annealing protein folding computational biology quantum computing molecular dynamics

Optimizing drug discovery pipelines with computational retrosynthesis and AI-driven reaction prediction

computational retrosynthesis drug discovery AI prediction synthetic pathways pharmaceutical optimization

Gut-brain axis modulation through epigenetic reprogramming of microbiome metabolites

gut-brain axis epigenetic reprogramming microbiome metabolites neurotransmitters neurological health

Automated retrosynthesis for drug discovery using quantum annealing methods

retrosynthesis quantum annealing drug discovery computational chemistry optimization

Via quantum annealing methods to solve protein folding problems in neurodegenerative disease research

quantum computing protein folding neurodegenerative diseases quantum annealing computational biology

Harnessing neutrino physics for advanced non-invasive medical imaging diagnostics

particle physics medical diagnostics imaging innovation neutrino detectors healthcare technology

Measuring synaptic time delays to map neural communication in neurodegenerative diseases

neurobiology synaptic transmission brain disorders time-resolved imaging cognitive decline

Optimizing synaptic vesicle recycling pathways for neurodegenerative disease therapeutic targets

synaptic vesicles neurodegeneration drug targets neuroscience vesicle recycling